Fuji Pharma Co., Ltd. (FRA:FUP)

Fuji Pharma Revenue

In the fiscal year ending September 30, 2025, Fuji Pharma had annual revenue of 51.68B JPY with 12.01% growth. Fuji Pharma had revenue of 14.72B in the quarter ending September 30, 2025, with 13.40% growth.

• Revenue: 51.68B JPY
• Revenue Growth: +12.01%
• P/S Ratio: 0.86
• Revenue / Employee: 29.36M JPY
• Employees: 1,760
• Market Cap: 254.48M EUR

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	51.68B	5.54B	12.01%
Sep 30, 2024	46.14B	5.25B	12.84%
Sep 30, 2023	40.89B	5.46B	15.42%
Sep 30, 2022	35.43B	1.44B	4.22%
Sep 30, 2021	33.99B	197.00M	0.58%